Type 2 Diabetes (Pb 2019) Paperback

Approximately 29 million Americans are diagnosed with Type 2 diabetes each year, yet only about 36 percent (10.44 million individuals) achieve satisfactory medical outcomes, leaving many in need of additional support to effectively manage their glucose levels. Contrary to common belief, while anti-diabetic medications can help lower blood sugar, they often fall short in preventing long-term complications due to persistent inflammation in blood vessels. This book explores recent scientific discoveries highlighting that the damage caused by chronic high blood sugar (hyperglycemia) in Type 2 diabetes—affecting the cardiovascular system, kidneys, vision, peripheral nerves, and other organs—is primarily driven by excessive free radicals and reactive oxygen species (ROS). These harmful molecules trigger chronic systemic inflammation and impair the endothelial lining of blood vessels, disrupting the production of nitric oxide (NO), a crucial molecule for vascular health. This impairment significantly reduces blood flow to organs and tissues, leading to serious complications. Additionally, the book presents compelling evidence that long-term hyperglycemia causes extensive and often irreversible damage, sometimes even before a formal diabetes diagnosis is made. Given the limitations of conventional prescription treatments, this book also explores evidence-based complementary approaches for better blood sugar control and overall health management.